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Both iron overload and iron deficiency have been
associated with cardiomyopathy and heart failure,
but cardiac iron utilization is incompletely under-
stood. We hypothesized that the transferrin recep-
tor (Tfr1) might play a role in cardiac iron uptake
and used gene targeting to examine the role of Tfr1
in vivo. Surprisingly, we found that decreased iron,
due to inactivation of Tfr1, was associated with
severe cardiac consequences. Mice lacking Tfr1 in
the heart died in the second week of life and had
cardiomegaly, poor cardiac function, failure of mito-
chondrial respiration, and ineffective mitophagy. The
phenotype could only be rescued by aggressive iron
therapy, but it was ameliorated by administration of
nicotinamide riboside, an NAD precursor. Our find-
ings underscore the importance of both Tfr1 and
iron in the heart, and may inform therapy for patients
with heart failure.INTRODUCTION
Heart failure is a clinical disorder characterized by congestion
and decreased functional capacity that, despite current therapy,
continues to have a high mortality. While increased iron can
cause heart failure in iron overload disorders (Gulati et al.,
2014), iron insufficiency is a more common problem. Up to
50% of patients with heart failure are iron deficient, and iron defi-
ciency is associated with poor outcomes (Erbel et al., 2003).
Severe iron deficiency causes cardiomyopathy in animals (Me-
deiros and Beard, 1998; Petering et al., 1990), but previous
studies have neither dissociated cardiac iron deficiency from
systemic iron deficiency with anemia nor investigated its cellular
consequences.
Iron is essential for oxygen transport, oxidative phosphoryla-
tion, DNA synthesis, and other cellular processes. Iron co-fac-
tors—iron-sulfur (Fe-S) clusters and heme—are synthesized by
mitochondria and necessary for mitochondrial function. Mito-
chondria are abundant in cardiomyocytes to supply energy forCrepeated muscle contraction. Mitochondrial failure can lead to
increased reactive oxygen species and insufficient ATP. Accord-
ingly, clearance of dysfunctional mitochondria through mitoph-
agy is important for cardiomyocyte maintenance and function
(Jimenez et al., 2014).
Transferrin receptor (Tfr1, gene symbol Tfrc) promotes iron up-
take through the transferrin (Tf) cycle, by facilitating receptor-
mediated endocytosis of iron bound to serum Tf (Hentze et al.,
2004). Through targeted gene disruption in mice, we showed
that erythroid precursors require Tfr1, but other cells can
develop without it (Levy et al., 1999). Tfr1/ mice appeared
normal early in embryogenesis, but died by embryonic day
12.5 with anemia, pericardial effusion, edema, and a kinked
neural tube. We attributed the pericardial effusion and edema
to severe anemia but could not exclude cardiac dysfunction.
There were no anatomical defects in the embryonic heart, indi-
cating that heart structures did not require Tfr1 to form. However,
we now propose that Tfr1 is critically important for normal heart
function.
Mice with profound deficiency of Tf are viable but have severe
anemia (Trenor et al., 2000). They accumulate excess iron in
non-hematopoietic tissues, including the heart, confirming that
many cells can take up non-Tf-bound iron. Chimeric mice gener-
ated from blastocysts containing Tfr1/ embryonic stem cells
showed that non-hematopoietic tissues, including the heart,
could develop from cells lacking Tfr1 (Ned et al., 2003).
To determine whether Tfr1 is important in the heart, we dis-
rupted floxed Tfr1 in cardiomyocytes using Cre recombinase
expressed from a heart-specific promoter. Tfr1-null mice devel-
oped early, lethal cardiomyopathy with failure of oxidative
phosphorylation and ineffective mitophagy. The abnormalities
were prevented by iron supplementation to overwhelm the
capacity of serum Tf to bind iron. The lifespan of Tfr1-null
mice was prolonged by treatment with nicotinamide riboside
(NR), a substrate for NAD production. Our results demonstrate
a stringent requirement of cardiomyocytes for Tfr1-mediated
iron uptake, and they show defects in oxidative phosphoryla-
tion and mitophagy caused by iron deficiency. Our findings
give insight into how isolated cardiac iron deficiency leads
to cardiac dysfunction, and they suggest possible therapeutic
approaches for patients with heart failure complicated by iron
deficiency.ell Reports 13, 533–545, October 20, 2015 ª2015 The Authors 533
RESULTS
Tfr1 Deficiency Causes Cardiomyopathy
We inactivated murine Tfr1 in cardiomyocytes by expressing a
Myh6-Cre transgene (Agah et al., 1997) to recombine loxP sites
flanking exons 3–6 (Figure S1A). We confirmed that mutant
(Tfr1hrt/hrt) animals expressed little Tfr1 mRNA in heart (Fig-
ure S1B) and that Tfr1 was not deleted in other tissues (data
not shown). Tfr1hrt/hrt mice were born in Mendelian ratios and
maintained body weights similar to wild-type (WT) littermates
(Tfr1fl/fl and Tfr1fl/+ mice, Figures 1A and S1C), but they died after
several hours of distress by post-natal day 11 (P11) with cardiac
hypertrophy (Figure 1B) and elevated heart-to-body weight ra-
tios, which had developed over time (Figure 1C).
Echocardiography of Tfr1hrt/hrt mice was normal at P5 but
showed left ventricular dilatation and decreased fractional short-
ening at P10 (Figures 1D–1F), indicating compromised cardiac
performance. Wheat germ agglutinin staining showed normal
Tfr1hrt/hrt cardiomyocyte size at P5 but enlarged cardiomyocytes
at P10, consistent with hypertrophy (Figure 1G). At P5 mRNA
encoding one biomarker for cardiac hypertrophy, Nppb, was
increased, but Acta1, another biomarker, was decreased (Fig-
ure 1H). However, at P10 all cardiac hypertrophy biomarkers
examined (Nppa, Nppb, Myh7, and Acta1) were significantly
increased. Thus, deletion of Tfr1 in cardiomyocytes leads to
dilated cardiomyopathy over the first 10 days of life.
Cardiac Iron Deficiency
The canonical function of Tfr1 is to supply iron to meet cellular
needs. We measured non-heme cardiac iron to determine
whether loss of Tfr1 resulted in iron deficiency. While tissue
iron concentration increased over time in WT animals, it was
decreased at birth and did not change substantially in Tfr1hrt/hrt
hearts (Figures 2A–2C). The total iron concentration at P10
also was decreased in Tfr1hrt/hrt mice (Figure 2D). Fe-S clusters
are synthesized from non-heme iron, and the amounts of en-
zymes Dpyd and Ppat decrease when Fe-S clusters are not
available (Stehling et al., 2013). Both proteins were deficient in
Tfr1hrt/hrt hearts at P7–P10 (Figures 2E and S1D), consistent
with compromised Fe-S cluster biogenesis due to iron deficiency
or mitochondrial dysfunction. We conclude that Tfr1 is important
for iron uptake by cardiomyocytes.
Metabolic Changes Associated with Cardiomyopathy
Mitochondria from Tfr1hrt/hrt hearts were slightly abnormal at P5,
but severely disrupted and enlarged at P10 (Figure 3A). Fe-S
clusters and heme are required by most complexes of the elec-
tron transport chain (ETC) (Xu et al., 2013).We immunoblotted for
proteins that are labile when ETC complexes are not assembled
properly. At P5 complex II was decreased in Tfr1hrt/hrt hearts and
complex IV was increased, but the other ETC complexes did not
differ from controls (Figure 3B). At P10 complexes I–IV were all
diminished in Tfr1hrt/hrt hearts (Figure 3C). Activity of complex II
was decreased at P5 (Figure 3D), and activities of complexes
I–IV were all markedly decreased at P10 in Tfr1hrt/hrt hearts (Fig-
ure 3E) at P10. However, complex V, which does not contain iron,
appeared unchanged at both ages, and its activity was not
decreased in Tfr1hrt/hrt hearts at P10 (Figure S2A). Expression534 Cell Reports 13, 533–545, October 20, 2015 ª2015 The Authorsof mitochondria-encoded mRNA for Polrmt, Nd4, Cytb, and
Cox3 was similar to WT at P5 (data not shown), but by P10
all were decreased in Tfr1hrt/hrt hearts (Figure 3F), suggesting
fewer mitochondria or mitochondria incapable of normal gene
expression.
We profiled mRNA expression in Tfr1hrt/hrt hearts at P10
(results deposited at GEO: GSE68745) and looked for patterns
using gene set enrichment analysis (Mootha et al., 2003; Subra-
manian et al., 2005). Genes downregulated in the mutants were
significantly associated with PPAR (particularly PPARa) and
PGC1-a signaling, myogenesis, insulin signaling, and cardiomy-
opathy. Upregulated genes included hypoxia-inducible targets,
Myc targets, and glycolytic enzymes.
We confirmed decreased expression of PGC1-a (Ppargc1a)
and PGC1-b (Ppargc1b) mRNA in Tfr1hrt/hrt hearts (Figure 3G)
as well as PGC1-a protein (Figure S2B). PGC1-a controls tran-
scription of a suite of nuclear genes to induce mitochondrial
biogenesis (Lehman et al., 2000;Wu et al., 1999b). Mice deficient
in PGC1-a in the heart develop cardiomyopathy, similar to our
mutant mice (Arany et al., 2005). Our results suggest impaired
ability to induce mitochondrial biosynthesis.
Cardiomyopathy is associated with a switch to fetal-like meta-
bolism, with glucose, rather than fatty acids, as the preferred
energy source (van Bilsen et al., 1998). The switch has been
attributed to decreased activity of PPARa (Ppara) (Barger
et al., 2000), which forms a heterodimer with Rxr. Expression
of Ppara andRxrgwas decreased in Tfr1-null hearts, as was fatty
acid transport protein (Fatp1/Slc27a1, Figure 3H). These
changes were not apparent earlier at P5. Interestingly, Ppara
expression is induced by the histone demethylase Kdm3a
(Okada et al., 2010), which requires iron (Yamane et al., 2006).
Ppara and other genes induced by Kdm3a, Ucp2 and Acadm,
had decreased mRNA levels at P10, but were not decreased at
P5 (data not shown). We hypothesize that iron deficiency caused
decreased Ppara expression, contributing to the metabolic
switch.
At P10 we observed increased mRNA expression of hypoxia-
inducible genes (Figure 4A) and glycolytic enzymes (Figure 4B).
Of the glycolytic enzymes, only Pfkl was slightly increased at
P5 (data not shown). Iron is a cofactor for hydroxylases that
cause HIFa transcriptional factors to be inactivated, suggesting
that iron deficiency could explain induction of hypoxia-inducible
genes (Kaelin and Ratcliffe, 2008). In addition, Myc, which in-
duces expression of glycolytic enzymes, was upregulated (Fig-
ures 4C and S3). However, glycolysis cannot meet energy needs
of cardiomyocytes, which depend on mitochondrial respiration.
Apoptosis was increased in Tfr1hrt/hrt hearts, consistent with
severe mitochondrial dysfunction, but only at P10 and not earlier
at P5 (Figure 4D). These results suggest that iron deficiency
leads to mitochondrial insufficiency, metabolic changes, and
increased apoptosis, contributing to cardiomyocyte hypertrophy
and cardiac dysfunction.
Interruption of Mitophagy
Mitochondrial damage should activate mitophagy to clear
dysfunctional organelles and recover iron for re-use. Glycolytic
enzyme Hk2 promotes autophagy during energy deprivation
(Roberts et al., 2014) and was not upregulated at P5 (data not
Figure 1. Loss of Tfr1 in Cardiomyocytes Causes Cardiomyopathy
(A) Tfr1hrt/hrt mice appeared grossly similar to WT at P10.
(B) H&E staining of heart sections at P10 demonstrates cardiomegaly in Tfr1hrt/hrt mice. Scale bars, 1 mm.
(C) Tfr1hrt/hrt mice had normal heart-to-body weight ratios at P5, but cardiomegaly was apparent at P8 and P10.
(D) Echocardiograms from representative Tfr1hrt/hrt and WT littermates at P5 (top) and P10 (bottom). For each age, the short axis (top) and long axis (bottom) are
shown. Tfr1hrt/hrt mice have markedly impaired cardiac function at P10.
(E and F) Left ventricular diameter and fractional shortening were normal at P5, but abnormal in Tfr1hrt/hrt mice at P10. LVDd, left ventricular diameter in diastole;
LVDs, left ventricular diameter in systole.
(G) Representative images of WGA staining for cardiomyocyte morphometrics and quantitation show Tfr1hrt/hrt cardiomyocyte area similar to WT at P5 (top) and
enlarged Tfr1hrt/hrt cardiomyocytes at P10 (bottom). Scale bars, 15 mm.
(H) The mRNA levels of cardiac hypertrophy biomarkers at P5 and P10, as described in the text, are shown.
Data are presented as means ± SEM. Sample size (n) is indicated. *p < 0.05, **p < 0.01, and ***p < 0.001 by one-way ANOVA. See also Figure S1.
Cell Reports 13, 533–545, October 20, 2015 ª2015 The Authors 535
Figure 2. Iron Deficiency and Fe-S Cluster
Insufficiency in Tfr1hrt/hrt Mice
(A–C) Non-heme iron levels in WT and mutant
heart at P0 (A), P5 (B), and P10 (C) are shown.
(D) Total iron concentration at P10 is shown.
(E) Decreased Fe-S cluster proteins Dpyd and
Ppat in hearts from Tfr1hrt/hrt mice; Rpl19 is the
control. Ages and genotypes are shown (top).
Data are presented as means ± SEM. Sample size
(n) is indicated. ***p < 0.001 by one-way ANOVA.shown), but was substantially induced at P10 (Figures 4B, 5A,
and S4A). Both isoforms of Rcan1, which also induces mitoph-
agy (Ermak et al., 2012) and protects against apoptosis due to
hypoxia (Yan et al., 2014), were upregulated in P10 Tfr1hrt/hrt
hearts (Figures 5B, S4B, and S4C).
We characterized mitophagy by using tissue because
neonatal mouse cardiomyocytes cannot be cultured efficiently
without contaminating cells. Expression of putative mitophagy
receptors, Nix (Bnip3l) and Fundc1 (Liu et al., 2012; Novak
et al., 2010), was decreased in Tfr1hrt/hrt hearts at P8 and P10
(Figures 5C, 5D, S4D, and S4E). Ulk1, which phosphorylates
Fundc1 to clear damaged mitochondria (Wu et al., 2014), also
was decreased (Figures 5C, 5D, S4D, and S4F). Bnip3, a homo-
log of Nix, was markedly increased in mutant hearts as early as
P5 (Figures 5E and S4G; data not shown). Bnip3 triggers opening
of the mitochondrial permeability transition pore and loss of
mitochondrial membrane potential (Regula et al., 2002), but
may not function as a mitophagy receptor. Bnip3 is induced by
hypoxia-inducible factors (Bruick, 2000), consistent with upre-
gulation of other hypoxia-inducible genes. Overall, our results
suggest that molecules important for cargo recognition were
deficient.
Map1lc3 (LC3) and Gabarap also are involved in the cargo
recognition step of autophagy. LC3-II, a phosphatidylethanol-
amine (PE)-conjugated form of LC3, increases during active
autophagy, but was decreased in heart samples from Tfr1hrt/hrt
mice at P5 and decreased more at P8 and P10 (Figures 5F–5H,
S4H–S4J, and S4L). Gabarap-II also was decreased at P10 (Fig-
ures 5H and S4K).
We evaluated other proteins involved in early steps of auto-
phagy. Cisd2 (Naf-1), an Fe-S cluster protein associated with
the mitochondrial membrane, is depleted in Tfr1hrt/hrt mice
(Figures 5I and S4M). Deficiency of Cisd2 should promote auto-
phagy by liberating Beclin-1 from Bcl2 (Chang et al., 2010). Be-
clin-1 levels were similar in mutant andWT hearts (Figures 5I and
S4N) but we could not assess its activity. Atg16L, involved early
in formation of the phagophore, was increased in P10 Tfr1hrt/hrt
hearts (Figures 5J and S4J). Atg10, which was decreased (Fig-536 Cell Reports 13, 533–545, October 20, 2015 ª2015 The Authorsures 5J and S4O), is an E2-like enzyme
involved in both Atg12-Atg5 conjugation
and LC3 conjugation to PE (Nemoto
et al., 2003). While LC3-II was decreased
(Figures 5F–5H, S4HS4J, and S4L),
Atg12-Atg5 was increased in mutant
hearts (Figures 5J and S4J). The Atg12-
Atg5 complex forms before conjugationof LC3 (Geng et al., 2008). Knockdown of LC3 or Gabarap leads
to maintenance of the Atg12-Atg5 complex (Weidberg et al.,
2010), consistent with our observations. Atg4b cleaves the
carboxyl termini of LC3 and Gabarap to expose their lipidation
sites, but it also de-lipidates both proteins. Overexpression of
Atg4b thus inhibits membrane localization and PE conjugation
of LC3 (Tanida et al., 2004). Atg4b was increased in Tfr1hrt/hrt
hearts (Figures 5J and S4O), possibly contributing to decreased
levels of LC3-II andGabarap-II. Atg7, an E1-like enzyme involved
in the development of autophagosomes, and Atg3, an E2-like
enzyme for the LC3/Gabarap conjugation system, were both
increased in Tfr1hrt/hrt mice (Figures 5J and S4J). These results
suggest that mutant heart cells were attempting to initiate mi-
tophagy, but key proteins involved in cargo recognition were
deficient.
Sqstm1 (p62) links the phagophore to cargo. During autopha-
gic flux, lysosomal enzymes degrade p62. The amount of p62
was similar to WT at P5 (Figure S4H), but it was increased in
Tfr1hrt/hrt hearts at P8 and P10 (Figures 5G, 5J, S4I, and S4J)
even though p62 mRNA was not increased (Figure S4P), sug-
gesting that p62 was not degraded. We examined cathepsin D
(Ctsd), an indicator for lysosomal function. Both forms of Ctsd
were increased in hearts from Tfr1hrt/hrt mice (Figures 5K and
S4Q), showing that lysosomes were functioning. Consistent
with a possible defect in cargo recognition, these results suggest
that a mitophagy step prior to autophagosome-lysosome fusion
was impaired.
Lipin1 (Lpin1) enhances transcription regulated by PPAR-a
and PGC-1a (Finck et al., 2006) and controls autophagic clear-
ance in skeletal muscle (Zhang et al., 2014). Lpin1 mRNA was
decreased in hearts from Tfr1hrt/hrt mice (Figure 5L), possibly
contributing both to the metabolic switch and the interruption
of mitophagy. Ndrg1 is induced by iron depletion (Le and Ri-
chardson, 2004) and upregulated in Tfr1hrt/hrt hearts (Figure 4A).
Overexpression of Ndrg1 suppresses LC3-II accumulation and
autophagosome formation (Kachhap et al., 2007; Sahni et al.,
2014). Atg9 delivers membrane components to developing auto-
phagosomes (Puri et al., 2014). Atg9 was increased in Tfr1hrt/hrt
Figure 3. Abnormal Mitochondrial
Morphology and Function in Hearts from
Tfr1hrt/hrt Mice
(A) Electron micrographs comparing mitochondria
in WT and Tfr1hrt/hrt hearts. Tfr1hrt/hrt mitochondria
were slightly abnormal at P5 (top), but markedly
enlarged and disrupted at P10 (bottom). Scale
bars, 500 nm.
(B) Representative protein levels for ETC com-
plexes by immunoblot at P5, using complex V as
the standard, are shown.
(C) Representative protein levels for ETC com-
plexes by immunoblot at P10, using complex V as
the standard, are shown.
(D) Enzymatic activity of complex II of ETC from P5
Tfr1hrt/hrt and WT littermates is shown.
(E) Enzymatic activity of complexes I–IV of ETC
from P10 Tfr1hrt/hrt and WT littermates is shown.
(F) Relative mRNA levels of Polrmt and mito-
chondria-encoded genes at P10 are shown.
(G) Relative mRNA levels of PGC1-a (Ppargc1a)
and PGC1-b (Ppargc1b) at P10 are shown.
(H) Relative mRNA levels of PPARa (Ppara), Rxr
gamma (Rxrg), and fatty acid transport protein
(Fatp1) at P10 are shown.
Data are presented as means ± SEM. Sample size
(n) is indicated. *p < 0.05, **p < 0.01, ***p < 0.001
by one-way ANOVA. See also Figure S2.hearts (Figures 5J and S4O). Optn, also important in autopha-
gosome maturation (Tumbarello et al., 2012), was induced in
Tfr1hrt/hrt hearts (Figure 5M). These results reinforce the idea
that autophagy/mitophagy was generally stimulated, but cargo
recognition was defective in Tfr1hrt/hrt hearts.
Rescue of Tfr1hrt/hrt Mice
To test whether cardiac iron repletion could rescue Tfr1hrt/hrt
mice, we administered iron dextran at P3 to supersaturate Tf
and induce non-Tf-bound iron uptake. This prolonged survival,
but Tfr1hrt/hrt mice still died at 4 to 5weeks with severe cardiome-
galy.We confirmed that the hearts had assimilated iron by immu-Cell Reports 13, 533–545,noblotting for Fe-S cluster proteins. In
contrast to untreated Tfr1hrt/hrt mice,
Dpyd and Ppat levels were similar at
P10 in Tfr1hrt/hrt and WT mice treated
with iron dextran (Figure S5A). Proteins
representing ETC complexes were also
similar at P10 (Figure S5B). At that time
Tfr1hrt/hrt mice and WT littermates had
similar heart-to-body weight ratios (Fig-
ure S5C). To try to improve the rescue,
we administered a second dose of iron
dextran at P7. The onset of cardiomyop-
athy was further delayed and Tfr1hrt/hrt
mice survived up to 13 weeks. However,
ETC complexes already were decreased
in hearts from doubly treated Tfr1hrt/hrt
mice at 6–8 weeks of age (Figure S5D)
and the hearts already were enlarged
(Figure S5E). Together, these results indi-cate that iron-treated Tfr1hrt/hrt mice assimilated and used sup-
plemental iron to survive beyond their usual lifespan, but they
eventually showed abnormalities in mitochondrial ETC com-
plexes and autophagy-related proteins (data not shown) similar
to untreated Tfr1hrt/hrt mice at P10.
We hypothesized that the heart might require continuous
iron uptake and that iron administered early might no longer
be available for utilization. To sustain elevated plasma iron
concentrations, we took advantage of hemojuvelin knockout
(Hjv/) mice, which persistently have increased non-Tf-bound
iron (Huang et al., 2005). We generated Tfr1hrt/hrt;Hjv/ mice
in which Tfr1 was deleted in the heart and Hjv was deletedOctober 20, 2015 ª2015 The Authors 537
Figure 4. Metabolic Changes and Increased
Apoptosis in Hearts from Tfr1hrt/hrt Mice at
P10
(A) Relative mRNA levels of transcripts induced by
hypoxia are shown.
(B) Relative mRNA levels of transcripts encoding
enzymes of glycolysis are shown.
(C) Representative protein levels for Myc by
immunoblot at P10 are shown.
(D) TUNEL staining for apoptosis at both P10 and
P5. Top row is without DAPI staining of nuclei;
bottom row is with DAPI staining. Vertical pairs
from left to right are as follows: negative control,
positive control, and WT and Tfr1hrt/hrt at P10 and
P5, respectively. Bright green fluorescent nuclei
represent apoptotic cells. Scale bars, 100 mm.
Results are quantified (right); data are presented
as means ± SEM.
Sample size (n) is indicated;*p < 0.05, **p < 0.01,
***p < 0.001 by one-way ANOVA. See also Fig-
ure S3.globally. These mice also died at P11, similar to Tfr1hrt/hrt mice.
However, it takes time for Hjv/ mice to accumulate iron.
We therefore treated Tfr1hrt/hrt;Hjv/ and control mice with iron
dextran atP3 to support theanimals until theHjvmutation caused
elevated iron levels. With this strategy, the Tfr1hrt/hrt;Hjv/
mice were healthy when sacrificed at 12 months and had heart-
to-body weight ratios (Figure S5F) similar to Tfr1fl/fl;Hjv/
controls.
We confirmed that this protocol restored cardiomyocyte iron
by immunoblotting for Dypd and ferritin at 10–11 weeks (Fig-
ure 6A). Markers for ETC complexes I to IV were indistinguish-
able between Tfr1hrt/hrt;Hjv/ mice and controls (Figure 6B).
Autophagy-related proteins LC3-II, p62, Fundc1, Nix, Ulk-1,
and Cisd2 showed no significant differences (Figures 6C–
6H). Collectively, these results indicate that the Tfr1hrt/hrt
mutant phenotype is primarily attributable to a defect in iron
assimilation, and iron deficiency results in cardiac hypertro-
phy, mitochondrial dysfunction, and interruption of mitophagy.
Further experiments will be needed to fully characterize the
defect in mitophagy. Importantly, it appears that the heart538 Cell Reports 13, 533–545, October 20, 2015 ª2015 The Authorsis highly sensitive to iron deprivation
due to inactivation of Tfr1 and requires
a continuous source of iron to function
normally.
Treatment with NR
Mitochondrial dysfunction can cause a
decreased NAD/NADH ratio and inactiva-
tion of sirtuin deacetylases (Nunnari and
Suomalainen, 2012). A decreased NAD/
NADH ratio might block signals for mito-
chondrial biogenesis while also causing
defective mitophagy (Fang et al., 2014).
Furthermore, in the absence of Sirt1,
LC3-II is decreased and p62 accumu-
lates (Hu et al., 2003), similar to what we
observed in Tfr1hrt/hrt mice. We specu-lated that augmentation of NAD levels might modify the mutant
phenotype.
We noted dramatic induction of mRNA encoding NR kinase 2
(Nmrk2/Itgb1bp3, Figure 7A) and the Slc3a2/Slc7a5 transport
system for theNADprecursor tryptophan (Boadoet al., 1999; Fig-
ure 7B), along with decreased expression of ADP-ribosyltrans-
ferases (Figure 7C), suggesting that mutant cardiomyocytes
were trying to increase cellular NAD levels. Mitochondria from
Tfr1hrt/hrt hearts showed increased lysine acetylation (Figure 7D),
consistentwith increasedacetylation or decreasedmitochondrial
sirtuin deacetylase activity due to decreasedmitochondrial NAD.
NR can be phosphorylated by Nmrk proteins to induce NAD
production, activating sirtuins and mitochondrial biogenesis
(Chi and Sauve, 2013). Considering that Nmrk2 (Itgb1bp3) was
induced in Tfr1hrt/hrt hearts (Figure 7A), we hypothesized that
NR might benefit the mutant animals. We administered NR and
observed up to 50% prolongation of lifespans of Tfr1hrt/hrt mice
(Figure 7E), indicating that NR could ameliorate the phenotype.
NRmight improve theNAD/NADH ratio by increasing NAD.We
attempted to measure NAD/NADH ratios without and with NR
Figure 5. Altered Expression of Molecules
Involved in Autophagy and Mitophagy in
Hearts from Tfr1hrt/hrt Mice
(A–J) Multiple autophagy- and mitophagy-related
genes were examined in P10 (A, B, D, E, and H–J),
P8 (C and G), and P5 (F) heart samples for protein
levels, as indicated. Differences suggested stim-
ulation of autophagy but failure to complete
autophagy in Tfr1hrt/hrt hearts. Sample sizes for
WT and Tfr1hrt/hrt not shown are as follows: (H) 14
WT and six Tfr1hrt/hrt mice; (I) three WT and five
Tfr1hrt/hrt mice for Cisd2; five mice each for Be-
clin1; and (J) five to six mice of each genotype
except for Atg4B (11 mice) and Atg3 (16 mice).
(K) Lysosomal cathepsin D (Ctsd) and its cleaved
intermediate were elevated in hearts from Tfr1hrt/hrt
mice, indicating normal lysosomal function.
(L) Lpin1 mRNA was decreased in hearts from
Tfr1hrt/hrt mice.
(M) Optineurin (Optn) mRNA was increased in
hearts from Tfr1hrt/hrt mice.
Data are presented as means ± SEM. Sample size
(n) is indicated; *p < 0.05, **p < 0.01, ***p < 0.001
by one-way ANOVA; n.s., not significant. See also
Figure S4.treatment, but our results from tissue were unreliable. Alterna-
tively, NR may enhance the mitochondrial unfolded protein
response (UPRMT; Khan et al., 2014). Although not apparent at
P5 (data not shown), we observed increased mRNA for multiple
genes associated with the UPRMT in P10 hearts, including Atf4,
Lonp1, Ddit3, and Fgf21 (Figure 7F). In contrast to the earlier
report (Khan et al., 2014), NR treatment was associated withCell Reports 13, 533–545,decreased expression of UPRMT mRNAs
(Figure 7F). Furthermore, NR alleviated
the accumulation of p62 in the Tfr1hrt/hrt
hearts (Figure 7G). It appears that NR im-
proves mitochondrial quality or enhances
mitophagy in Tfr1hrt/hrt hearts, but under-
standing its beneficial effect will require
more work.
DISCUSSION
Iron overload has long been known to
cause cardiomyopathy, but relatively little
was previously understood about the
molecular consequences of cardiac iron
deficiency. Iron deficiency has been impli-
cated in the pathogenesis of heart failure,
even in the absence of frank anemia, but
previous animal models of cardiomyopa-
thy have involved systemic iron deficiency
(Medeiros andBeard, 1998;Peteringet al.,
1990), which also causes anemia, con-
founding the interpretation of the role of
iron in the heart. In the course of eluci-
dating how cardiomyocytes assimilate
iron, we developed a mouse mutant thatallowed us to examine the consequences of isolated cardiac
iron deficiency. We observed that mice lacking Tfr1 in the heart
died from early onset cardiac hypertrophy, caused by iron defi-
ciency and associated with mitochondrial failure. There was
induction of a protective mitophagy response, as expected, but
failure to complete mitophagy due to inhibition of cargo recogni-
tion or another step early in the mitophagy pathway.October 20, 2015 ª2015 The Authors 539
Figure 6. Rescue of Tfr1hrt/hrt Mice with
Continuous Iron
Iron overload achieved by Fe dextran adminis-
tration to mutant animals and WT littermates at P3
and an Hjv/ hemochromatosis background
provided sufficient iron to fully rescue Tfr1hrt/hrt
mice.
(A) Dpyd and H-ferritin levels at 10 weeks are
shown.
(B) Proteins representative of ETC complexes at
10 weeks are shown.
(C–H) Markers of autophagy are shown as indi-
cated at 10 weeks of age.
Data are presented as means ± SEM. Sample size
(n) is indicated; n.s., not significant by one-way
ANOVA. See also Figure S5.The iron deficit in Tfr1hrt/hrt hearts led to abnormal mitochon-
drial morphology and ETC function, similar to frataxin-deficient
mice with impaired Fe-S cluster biogenesis (Puccio et al.,
2001). Gene expression results suggested impaired mitochon-
drial biogenesis. A link between iron and mitochondrial biogen-
esis was reported previously by Rensvold et al. (2013), who
screened for genes induced by overexpression of PGC-1a in
muscle cells. They observed induction of Tfr1mRNA, suggesting
that iron uptake is stimulated when mitochondria are needed.
They showed that iron deprivation causes a reversible decrease
in expression of nuclear genes encoding ETC proteins, which are
regulated by PGC-1a. We similarly observed decreased mRNA
levels of Ndufab1, Ndufb2, Ndufb4, Ndufs4, Sdh, Cox7b2,
Cox15, Atp5e, and Atp5g (data not shown) along with genes
encoding PGC-1a and PGC-1b and PGC-1a protein. Our obser-
vations support the conclusion that regulation of mitochondrial
biogenesis is functionally linked to Tfr1 and cellular iron homeo-
stasis. Tfr1 also has been linked to mitochondrial biogenesis in
osteoclasts, where iron uptake stimulated expression of PGC-
1b, while iron chelation blunted it (Ishii et al., 2009).
Tfr1hrt/hrt cardiomyocytes increased expression of all enzymes
of glycolysis as well as other hypoxia-inducible genes. These
changes may be attributable, in part, to stabilization of HIFa
proteins when the iron supply is insufficient for function of hy-540 Cell Reports 13, 533–545, October 20, 2015 ª2015 The Authorsdroxylases that normally modify HIFa
proteins to cause their degradation and
inactivation. Additionally, many upregu-
lated genes are targets of Myc, which
was increased in Tfr1hrt/hrt hearts. Myc
regulates genes to promote iron uptake
(Wu et al., 1999a), and Tfr1 itself is a
Myc transcriptional target (O’Donnell
et al., 2006). Increased expression of
Myc is an appropriate response to cellular
iron deficiency, but futile in the absence
of Tfr1.
Myc also contributes to mitochondrial
biogenesis (Karamanlidis et al., 2013).
More than one-third of nucleus-encoded
mitochondrial genes are Myc targets,
and mitochondrial mass generally corre-lates with Myc expression. Myc is induced in cardiomyocytes
in response to stress, and it assists in the metabolic shift from
fatty acid oxidation to glucose oxidation, as observed in our
mice, by inducing glycolytic enzymes and downregulating fatty
acid oxidation enzymes by inhibiting PGC-1a expression.
While induction of glycolytic enzymesmakes sense in Tfr1hrt/hrt
cardiomyocytes with failing mitochondria, increased expression
of Myc and decreased expression of PGC-1a might provide
contradictory signals for mitochondrial biogenesis. Gomes
et al. (2013) recently reported that PGC-1a and Myc function in
distinct pathways, responding to different cues. Decreased
expression of mitochondria-encoded proteins can result from
decreased deacetylase activity, as might occur as a result of
an NAD deficit. Decreased deacetylase activity leads to stabili-
zation of Hifa proteins, and Hif-1a inhibits Myc-induced mito-
chondrial gene expression. In parallel, it leads to decreased
PGC-1a activity.
Mitophagy also is impaired in Tfr1hrt/hrt cardiomyocytes. Many
proteins involved in stimulating mitophagy are induced, but
levels of cargo recognition-related proteins Bnip3l (Nix), Fundc1,
Ulk1, LC3-II, Gabarap-II, and Atg10 are depressed and p62 ac-
cumulates in spite of normal lysosomal function. These changes,
alongwith decreased expression of Lpin1 and increased expres-
sion of Atg4b and Ndrg1, might explain the defect in mitophagy
Figure 7. Transient Rescue of Tfr1hrt/hrt Mice by Treatment with NR
(A) The mRNA encoding Nmrk2/Itgb1bp3 was massively increased in Tfr1hrt/hrt mice.
(B) The mRNAs encoding Slc3a2 and Slc7a5, components of the uptake system for tryptophan, an NAD precursor, were increased in Tfr1hrt/hrt mice.
(C) The mRNAs encoding ADP-ribosyltransferases Art1, Art4, and Art5 were markedly decreased in Tfr1hrt/hrt mice.
(D) Proteins from mitochondria isolated from Tfr1hrt/hrt heart showed increased lysine acetylation.
(E) Administration of NR, an NAD precursor and Nmrk2 substrate, extended the lifespan of Tfr1hrt/hrt mice for up to 5 days.
(F) Levels of UPRMTmRNAs in hearts fromWT and Tfr1hrt/hrt mice that were untreated (control group, left) or treated with NR (right). NR treatment appears to have
blunted the UPRMT response.
(G) The p62 protein levels in hearts from WT and Tfr1hrt/hrt mice that were untreated or treated with NR are shown.
Data are presented as means ± SEM. The p values for (A)–(C) and (F) were determined by one-way ANOVA. Sample size (n) is indicated; p value for (E) was
determined by log-rank test as described in the Supplemental Experimental Procedures; p value for (G) was determined by two-way ANOVA followed by
Bonferroni correction; *p < 0.05, **p < 0.01, ***p < 0.001.
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progression. However, it is also possible that mitophagy is inter-
rupted due to decreased availability of NAD to activate Sirt1, and
consequent increased acetylation of autophagy-related proteins
as previously reported (Hu et al., 2003). Similar to our results,
Sirt1/ mice exhibited abnormal cardiac mitochondria and
increased accumulation of p62.
Normally, autophagy and mitophagy replete cellular nutri-
ents, particularly at times of stress. The failure of mitophagy in
Tfr1hrt/hrt mice suggests that damaged mitochondria, which are
rich in iron, cannot be effectively broken down to recover iron
for re-use. This would set up a vicious cycle, in which iron defi-
ciency compromises mitochondrial integrity, but new iron is
not available for new mitochondrial biogenesis. We speculate
that this explains why the phenotype of Tfr1hrt/hrt mice is so se-
vere. Iron is present in the mutant cardiomyocytes, but may
not be effectively used, exacerbating cellular distress.
We showed that the phenotype of our Tfr1hrt/hrt mice could be
corrected through aggressive and ongoing iron supplementa-
tion, confirming that iron deficiency is the root cause for the
abnormalities. Nonetheless, treatment with NR prolonged the
lifespan of our mice. The response to NR is reminiscent of other
studies where it increases NAD, sirtuin activity andmitochondrial
biogenesis (Canto´ et al., 2012; Cerutti et al., 2014). NR was pre-
viously reported to stimulate the UPRMT (Khan et al., 2014), but
we observed the opposite. An increased NAD/NADH ratio and
activation of Sirt1 also lead to induction of autophagy (Hu
et al., 2003; Huang et al., 2003). We found that NR treatment
alleviated the accumulation of p62, suggesting improvement
of autophagy/mitophagy in Tfr1hrt/hrt hearts. Regardless of its
mechanism of action, catastrophic failure of the ETC, due to
iron deficiency, cannot be overcome, and the benefits of NR
are transient.
Our findings in mice provide mechanistic support for the
known benefit of iron treatment in heart failure accompanied
by iron deficiency. We showed that iron is not only necessary
for cardiac function, but also must be continuously available.
Furthermore, our findings suggest that NR, a potent, NAD-
enhancing form of vitamin B3, might provide added benefit in
patients with cardiac iron deficiency.EXPERIMENTAL PROCEDURES
See the Supplemental Experimental Procedures.
Animals
All animal studies were carried out under protocols approved by the Duke Uni-
versity Animal Care and Use Committee. Animal housing, care, and husbandry
were overseen by the Duke Department of Laboratory Animal Resources,
which is accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC).
We crossed 129/SvEv mice bearing a floxed Tfrc allele (Chen et al., 2015)
with transgenic C57BL/6 mice expressing Cre recombinase under the control
of the a-MyHC promoter (Agah et al., 1997). We backcrossed with 129/SvEv
mice for more than ten generations, and, after the initial phenotypic character-
ization, all studies used mice with a homogeneous 129/SvEv background. An-
imals were genotyped by PCR using genomic DNA from toe clips (Mizutani
et al., 2002). Primers for Tfrc alleles, Cre, and Hjv alleles are described in the
Supplemental Experimental Procedures.
For iron rescue experiments, mice were injected intraperitoneally (i.p.) with
5 mg Uniferon 100 (25 ml) at P3, or at both P3 and P7. For NR rescue experi-542 Cell Reports 13, 533–545, October 20, 2015 ª2015 The Authorsments, mice were injected i.p. with NR in PBS as previously described (Yang
et al., 2007) at 750 mg/kg daily from P5. Volume was based on body weight,
with less than 100 ml at P10. Control animals were injected with PBS only.
Histology
Paraffin sections (4 mm) were stained with H&E for light microscopy. Cardio-
myocyte dimensions were measured by digital morphometry of paraffin-
embedded myocardial cross-sections stained with Alexa Fluor 594 WGA
(Life Technologies, Invitrogen) using ImageJ image processing. Apoptotic cells
were identified and quantified using the In Situ Cell Death Detection Kit (Roche)
on paraffin sections according to the manufacturer’s instructions. Quantitation
was done by ImageJ using three consecutive sections for each mouse.
Echocardiography
Echocardiography was performed without anesthesia on age-, sex-, and body
weight-matched mice by an investigator blinded to genotypes. Left ventricular
dimensions and fractional shortening were calculated based on echocardiog-
raphy data as described previously (Esposito et al., 2000).
Electron Microscopy
Hearts were removed, rinsed in cold Krebs-Henseleit buffer (Krebs andHense-
leit, 1932), and immersed in 5%glutaraldehyde buffer. Samples were prepared
for transmission electron microscopy and imaged by Duke Research Electron
Microscopy Services.
Tissue Iron Analysis
Heart non-heme iron wasmeasured as described previously (Levy et al., 1999;
Torrance and Bothwell, 1980).
Analysis of ETC Complexes I–V
Tissues were homogenized in 250 mM sucrose, 40 mM potassium chloride,
1 mM EGTA, 1 mg/ml fatty acid-free BSA, 20 mM Tris-HCl (pH 7.2), and
homogenates were centrifuged at 600 3 g for 10 min at 4C. Steady-state
activities of enzyme complexes I–IV in the supernatant were determined
as previously described (Janssen et al., 2007; Spinazzi et al., 2011). For com-
plex V, crudemitochondria were collected and activity was determined as pre-
viously described (Kirby et al., 2007).
Preparation of Mitochondrial Lysates and Acetyl-Lysine Analysis
Mouse hearts were homogenized (40–50 strokes) in 15 vol of ice-cold homog-
enization buffer (320 mM sucrose, 50 mM KH2PO4 [pH 7.4], 10 mM Tris-HCl
[pH 7.4], and 1 mM EDTA) in the presence of protease inhibitors, phosphatase
inhibitors (Roche), and deacetylase inhibitors (2.5 mM Trichostatin A, 5 mM
nicotinamide, and 5 mM sodium butyrate) using glass homogenizers. Crude
mitochondria were isolated by differential centrifugation. Homogenates were
centrifuged at 1,600 rpm for 10 min at 4C. The supernatant was centrifuged
again at 1,600 rpm for 10 min at 4C. The supernatant subsequently was
centrifuged at 10,000 3 g for 10 min at 4C. The pellet was collected, rinsed
with 1 ml homogenization buffer, and centrifuged at 10,000 3 g again for
10 min at 4C. The pellet was resuspended in 100 ml 20 mM HEPES
(pH 7.4), 150 mM NaCl, and 1% Triton X-100 with protease, phosphatase,
and deacetylase inhibitors. Western blot analysis was performed with 70 mg
protein per lane. Antibodies recognizing acetyl-lysine were from Cell Signaling
Technology.
Statistical Analysis
One-way ANOVA was performed for comparisons between two means.
Two-way ANOVA followed by Bonferroni post hoc was performed for multiple
comparisons. Survival analysis was performed using log rank (see the Supple-
mental Experimental Procedures). Dr. Kingshuk Roy Choudhury (Duke Depart-
ment of Biostatistics and Bioinformatics) assisted with statistical analyses (p <
0.05 was considered statistically significant).
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